(Q37775634)

23 August 2017

1 reference

title

Prognostic biomarkers in malignant lymphomas (English)

1 reference

23 August 2017

0 references

1

Randy D Gascoyne

1 reference

23 August 2017

2

Andreas Rosenwald

1 reference

23 August 2017

Sibrand Poppema

3

1 reference

23 August 2017

Georg Lenz

series ordinal

4

1 reference

23 August 2017

publication date

1 August 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

51 Suppl 1

1 reference

23 August 2017

page(s)

11-19

1 reference

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Molecular pathogenesis of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Molecular biology and genetics of lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Prognostic biomarkers in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Cell cycle deregulation in B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

The P53 pathway: what questions remain to be explored?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Stromal gene signatures in large-B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

The biology of human lymphoid malignancies revealed by gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Biomarkers and prognosis in malignant lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

RETRACTED: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Gene expression signatures in follicular lymphoma: are they ready for the clinic?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Follicular lymphoma international prognostic index.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

The role of cytokines in classical Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Chemokines: a new classification system and their role in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

The CD4+CD26- T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Ongoing Improvement in Outcomes for Patients Diagnosed as Having Non-Hodgkin Lymphoma From the 1990s to the Early 21st Century

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500046

10.3109/10428194.2010.500046

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference